ENDOMETRIOID ADENOCARCINOMA
Clinical trials for ENDOMETRIOID ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktails show promise against tough endometrial cancer
Disease control OngoingThis study tests several drug combinations in women with endometrial cancer that has returned or not responded to treatment. The drugs work by blocking cancer cell growth or helping the immune system attack tumors. The goal is to see if these combinations can slow or stop the can…
Matched conditions: ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
Immunotherapy duo takes on rare cancers in Largest-Ever trial
Disease control OngoingThis study tested a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 different rare tumor types. The goal was to see if these drugs could shrink tumors and help control the cancer. The trial is no longer recruiting, and results are bein…
Matched conditions: ENDOMETRIOID ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC